Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement